Introduction
This joint guidance report explores good public health practices that can support effective policies to reduce infections. Common blood-borne viruses in this group include HIV, hepatitis B and hepatitis C. These are mainly spread through the sharing of needles, syringes and drug preparation equipment or unprotected sexual contacts. A short (8p.) version exists.
Notes on translations:
- Croatian (translated and produced within the framework of regional projects implemented by the EMCDDA’s Reitox and International cooperation unit)
- Czech (translated and produced by the Office of the Government of the Czech Republic)
- Estonian (translated and produced by National Institute for Health Development, Estonia)
- Hungarian (translated and produced by the Hungarian National Focal Point)
- Polish (translated and produced with the support of the Global Drug Policy program, Open Society Foundations)
- Turkish (translated and produced within the framework of regional projects implemented by the EMCDDA’s Reitox and International cooperation unit)
- Albanian (translated and produced within the framework of regional projects implemented by the EMCDDA’s Reitox and International cooperation unit)
- Bosnian (translated and produced within the framework of regional projects implemented by the EMCDDA’s Reitox and International cooperation unit)
- Macedonian (translated and produced within the framework of regional projects implemented by the EMCDDA’s Reitox and International cooperation unit)
- Serbian (translated and produced within the framework of regional projects implemented by the EMCDDA’s Reitox and International cooperation unit)
- Russian (translated and produced by National Institute for Health Development, Estonia)
Download as ePub
Table of contents
- Acronyms and glossary
- Executive summary
- Introduction
- Core values of prevention of infections among people who inject drugs
- Recommended interventions for the prevention of infections among people who inject drugs
- Knowing and understanding the national situation
- Monitoring problem drug use an d responses
- Surveillance of infections
- Monitoring and evaluation of programmes
- Setting targets for intervention coverage
- Annex
- References